Sale!

CCDC65 Gene Primary Ciliary Dyskinesia Type 27 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the CCDC65 gene responsible for Primary Ciliary Dyskinesia Type 27. This specialized genetic test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations that impair ciliary function, leading to chronic respiratory conditions, sinus infections, and fertility issues. The test provides crucial information for accurate diagnosis, personalized treatment planning, and genetic counseling. Available for only $500 USD, this advanced genetic analysis helps patients and healthcare providers understand the underlying genetic causes of persistent respiratory symptoms and develop targeted management strategies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test

Comprehensive Genetic Testing for Respiratory Health

The CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with Primary Ciliary Dyskinesia (PCD) Type 27. This specialized test utilizes advanced Next-Generation Sequencing technology to provide precise genetic analysis, enabling healthcare providers to make informed decisions about patient care and treatment strategies.

What Does This Test Measure?

This comprehensive genetic test specifically targets the CCDC65 gene, which plays a critical role in the proper functioning of cilia – microscopic hair-like structures that line the respiratory tract and other body systems. The test detects:

  • Pathogenic mutations in the CCDC65 gene
  • Genetic variations affecting ciliary structure and function
  • Inherited patterns of Primary Ciliary Dyskinesia Type 27
  • Specific nucleotide changes and structural alterations

Who Should Consider This Test?

This genetic test is particularly recommended for individuals experiencing:

  • Chronic respiratory infections from early childhood
  • Persistent sinusitis and nasal congestion
  • Recurrent middle ear infections and hearing problems
  • Chronic cough with excessive mucus production
  • Fertility issues in both males and females
  • Family history of Primary Ciliary Dyskinesia
  • Situs inversus (organs positioned on opposite sides)

Clinical Benefits of Genetic Testing

Undergoing the CCDC65 Gene Primary Ciliary Dyskinesia Type 27 test provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out genetic causes of respiratory symptoms
  • Personalized Treatment: Enables targeted management strategies based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management to prevent complications
  • Comprehensive Care: Supports multidisciplinary approach involving ENT specialists and genetic counselors

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of genetic specialists:

  • Positive Result: Indicates the presence of pathogenic mutations in the CCDC65 gene, confirming Primary Ciliary Dyskinesia Type 27 diagnosis
  • Negative Result: Suggests no detectable mutations in the CCDC65 gene, though other genetic or non-genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Determines if you carry one copy of a mutated gene, which may be important for family planning

Test Information and Pricing

Test Component Details
Test Name CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty ENT Doctor
Department Genetics

Pre-Test Preparation

Before undergoing testing, we recommend:

  • Providing complete clinical history of respiratory symptoms
  • Participating in genetic counseling session
  • Developing a detailed family pedigree chart
  • Discussing testing implications with your healthcare provider

Nationwide Testing Availability

We have testing facilities conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Take Control of Your Respiratory Health

Don’t let unexplained respiratory symptoms control your life. The CCDC65 Gene Primary Ciliary Dyskinesia Type 27 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and effective treatment planning. Our team of genetic specialists and ENT doctors are ready to support you through every step of the testing process.

Ready to schedule your genetic test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and developing a personalized treatment approach.